31.74
Oscar Health Inc stock is traded at $31.74, with a volume of 3.45M.
It is up +0.80% in the last 24 hours and up +29.29% over the past month.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
See More
Previous Close:
$31.44
Open:
$31.7
24h Volume:
3.45M
Relative Volume:
0.47
Market Cap:
$9.55B
Revenue:
$13.30B
Net Income/Loss:
$-39.39M
P/E Ratio:
-52.07
EPS:
-0.6096
Net Cash Flow:
$2.80B
1W Performance:
+11.12%
1M Performance:
+29.29%
6M Performance:
+92.29%
1Y Performance:
+88.52%
Oscar Health Inc Stock (OSCR) Company Profile
Name
Oscar Health Inc
Sector
Industry
Phone
(646) 403-3677
Address
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
31.69 | 9.48B | 13.30B | -39.39M | 2.80B | -0.6096 |
|
UNH
Unitedhealth Group Inc
|
425.84 | 379.60B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
103.46 | 130.25B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
417.22 | 88.64B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
284.94 | 74.59B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
395.44 | 47.17B | 137.20B | 1.15B | 1.27B | 9.3439 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-04-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-06-26 | Initiated | Wolfe Research | Peer Perform |
| Apr-20-26 | Upgrade | Jefferies | Underperform → Hold |
| Feb-12-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-09-26 | Upgrade | UBS | Sell → Neutral |
| Jan-05-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Initiated | Stephens | Equal-Weight |
| Nov-26-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-15-25 | Downgrade | UBS | Neutral → Sell |
| Jul-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-02-25 | Initiated | Barclays | Underweight |
| Jun-24-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-24 | Initiated | Jefferies | Underperform |
| Nov-06-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-07-24 | Initiated | UBS | Neutral |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-22-24 | Initiated | Raymond James | Outperform |
| Nov-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-14-22 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-14-21 | Initiated | Goldman | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Mar-30-21 | Initiated | Wells Fargo | Overweight |
| Mar-29-21 | Initiated | BofA Securities | Buy |
| Mar-29-21 | Initiated | Cowen | Market Perform |
| Mar-29-21 | Initiated | Credit Suisse | Outperform |
| Mar-29-21 | Initiated | Goldman | Buy |
| Mar-29-21 | Initiated | Morgan Stanley | Overweight |
View All
Oscar Health Inc Stock (OSCR) Latest News
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance Australia
Trust linked to Oscar Health (OSCR) director sells 47,500 shares - Stock Titan
Oscar Health (NYSE:OSCR) Reaches New 1-Year HighTime to Buy? - MarketBeat
Oscar Health Inc (Derivatives) price today, OSCR to USD live price, marketcap and chart - CoinMarketCap
Oscar Health’s Mark Bertolini on making ‘healthcare work for all’ - Fast Company
Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Market Uncertainties with a Strong Revenue Growth - DirectorsTalk Interviews
Fideuram Intesa Sanpaolo Private Banking S.P.A. Buys Shares of 113,081 Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health (OSCR) CEO Purchases 1 Million Shares, Stock Rises - GuruFocus
OSCROscar Health Inc Dividends - Finviz
Bertolini buys Oscar Health (OSCR) shares for $11.92 million - Investing.com
Oscar Health stock turns $35.7M insider selling into a new 52-week high - MSN
Have Oscar Health Insiders Been Selling Stock? - simplywall.st
CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable - Yahoo Finance
Oscar Health (OSCR) Stock Surges After CEO's Share Sale Linked t - GuruFocus
OSCR Stock Rallies As Barclays Targets Aggressive Upside - timothysykes.com
Oscar Health CEO Bertolini sells $35.7 million in company stock - Investing.com
Oscar Health CEO Bertolini sells $35.7 million in company stock By Investing.com - Investing.com South Africa
Tax-driven Oscar Health (OSCR) CEO sale of 1.24M shares under 10b5-1 - Stock Titan
Oscar Health (NYSE:OSCR) Stock Price Up 8.1%Should You Buy? - MarketBeat
Oscar Health stock hits 52-week high at 30.68 USD By Investing.com - Investing.com South Africa
Oscar Health stock hits 52-week high at 30.68 USD - Investing.com
OSCR Stock On Track For 6-Month High: What’s Driving This Earnings Rally? - Stocktwits
Oscar Health (NYSE:OSCR) Slips on Revenue Miss in NYSE Composite - Kalkine Media
Oscar Health Inc (OSCR) Stock Down 3.2% but Still Overvalued -- GF Score: 79/100 - GuruFocus
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Price to sales forward of Oscar Health, Inc. – NYSE:OSCR - TradingView
Enterprise value to EBIT forward of Oscar Health, Inc. – NYSE:OSCR - TradingView
Oscar Health director Mario Schlosser sells $30.18m in stock - Investing.com UK
Form 4 Oscar Health Inc For: 30 June By Investing.com - Investing.com Nigeria
Oscar Health director Mario Schlosser sells $30.18m in stock By Investing.com - Investing.com Canada
Why Is OSCR Stock Rising Today? - Stocktwits
Price to earnings forward of Oscar Health, Inc. – NYSE:OSCR - TradingView
Enterprise value to revenue forward of Oscar Health, Inc. – NYSE:OSCR - TradingView
Oscar Health CEO Mark Bertolini sells $34.9m in company stock - Investing.com UK
Oscar Health, Inc. (OSCR) stock dips while market gains: Key facts - MSN
Form 4 Oscar Health Inc For: 29 June By Investing.com - Investing.com South Africa
Oscar Health CEO Mark Bertolini sells $34.9m in company stock By Investing.com - Investing.com Australia
Oscar Health (OSCR) CEO Mark Bertolini sells 1.2M shares for tax obligations - Stock Titan
Health Insurance Providers Stocks Q1 Recap: Benchmarking Oscar Health (NYSE:OSCR) - Yahoo! Finance Canada
Oscar Health (NYSE:OSCR) Reaches New 52-Week HighHere's Why - MarketBeat
SG Americas Securities LLC Cuts Holdings in Oscar Health, Inc. $OSCR - MarketBeat
Assenagon Asset Management S.A. Raises Stake in Oscar Health, Inc. $OSCR - MarketBeat
Liquidity Mapping Around (OSCR) Price Events - Stock Traders Daily
Oscar Health (OSCR) Surges 3.91% as Positive Momentum BuildsRevenue Growth Stocks - dars.gov.et
Oscar Health Inc (OSCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Oscar Health, Inc. (OSCR) declines more than market: Some information for investors - MSN
Form 4 Oscar Health Inc For: 25 June By Investing.com - Investing.com Nigeria
Form 144 Oscar Health For: 25 June By Investing.com - Investing.com Nigeria
OSCR Forecast — Price Target — Prediction for 2027 - TradingView
Oscar Health, Inc. Class A Actuals & Estimates (NYSE:OSCR) - TradingView
Insider Selling: Oscar Health (NYSE:OSCR) Director Sells $25,854,400.00 in Stock - MarketBeat
Oscar Health Inc Stock (OSCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oscar Health Inc Stock (OSCR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bertolini Mark T | Chief Executive Officer |
Jun 30 '26 |
Sale |
28.48 |
624,244 |
17,781,383 |
7,751,570 |
| Bertolini Mark T | Chief Executive Officer |
Jun 25 '26 |
Sale |
28.61 |
615,142 |
17,601,317 |
9,581,734 |
| Bertolini Mark T | Chief Executive Officer |
Jun 26 '26 |
Sale |
29.28 |
591,168 |
17,310,761 |
8,990,566 |
| Schlosser Mario | Director |
Jun 23 '26 |
Sale |
29.38 |
880,000 |
25,850,515 |
480,866 |
| Schlosser Mario | Director |
Jun 23 '26 |
Sale |
29.38 |
147,500 |
4,332,898 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):